Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...
The success of the mRNA-based vaccines against SARS-CoV-2 merely hint at the healthcare implications of mRNA technology. More mRNA-based vaccines are in the works, as are mRNA-based therapeutics ...
The study showed that the LNP method is more efficient at mRNA translation, reducing the need for potentially toxic doses. The new study describes the use of the LNP technology for Cas9 mRNA ...
Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 vaccine – based on technology also pioneered at Penn – appeared to ...
Investigators led by Pablo Penaloza-MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination ...